Skip to main content
Log in

Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI)

Aktualisierung des Positionspapiers der Deutschen Gesellschaft für Kardiologie

Quality criteria for the implementation of transcatheter aortic valve implantation

Update of the position paper of the German Cardiac Society

  • Positionspapier
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Neuere Studien- und Registerdaten zur kathetergestützten Aortenklappenimplantation (TAVI) haben eine Aktualisierung des 2015 veröffentlichten Positionspapiers der Deutschen Gesellschaft für Kardiologie (DGK) zu diesem Behandlungsverfahren notwendig gemacht. Vorgestellt werden die Ergebnisse von randomisierten Studien, in denen TAVI und chirurgischer Aortenklappenersatz bei Patienten mit mittlerem und niedrigem operativen Risiko verglichen werden, Daten zum Langzeitverlauf der ersten randomisierten Hochrisikopatienten sowie Analysen großer Populationsregister aus Deutschland und den USA. Daraus resultieren aktualisierte Indikationsstellungen für eine TAVI bei Patienten ≥85 Jahre, Patienten, die nach dem STS-Score oder dem logistischen EuroSCORE ein niedriges, mittleres oder hohes OP-Risiko haben, sowie bei Patienten mit vorbestehender Herz-OP oder eingeschränkter Gesamtprognose. Dieses Dokument ergänzt das Positionspapier der DGK von 2015.

Abstract

Recent scientific evidence on transcatheter aortic valve implantation (TAVI) has necessitated an update of the 2015 position paper of the German Cardiac Society (GCS) on this treatment modality. We present findings from randomised trials comparing TAVI and surgical aortic valve replacement in patients with intermediate and low operative risk, data on the long-term outcome of the first high-risk patients enrolled in randomised trials, and analyses of large population-based registries from Germany and the USA. They have resulted in updated indications for TAVI in patients ≥85 years, patients at low, intermediate, or high surgical risk according to the STS score or the logistic EuroSCORE, as well as patients with a history of cardiac surgery or patients with an impaired overall prognosis. This document complements the 2015 position paper of the GCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Möllmann H, Naber CK, Schunkert H, Thiele H, Hamm C (2015) Positionspapier zu Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI). Kardiologe 9:11–26

    Article  Google Scholar 

  2. Eltchaninoff H, Nusimovici-Avadis D, Babaliaros V, Spenser B, Felsen B, Cribier A (2006) Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1:438–444

    PubMed  Google Scholar 

  3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008

    Article  PubMed  Google Scholar 

  4. Ferrari M, Figulla HR, Schlosser M, Tenner I, Frerichs I, Damm C, Guyenot V, Werner GS, Hellige G (2004) Transarterial aortic valve replacement with a self expanding stent in pigs. Heart 90:1326–1331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Buellesfeld L, Gerckens U, Grube E (2008) Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 71:579–584

  6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2010) PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607. doi:10.1056/nejmoa1008232

    Article  CAS  PubMed  Google Scholar 

  7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  PubMed  Google Scholar 

  8. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, U.S. CoreValve Clinical Investigators (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798

    Article  CAS  PubMed  Google Scholar 

  9. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, PARTNER 2 Investigators (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620

    Article  CAS  PubMed  Google Scholar 

  10. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225

    Article  PubMed  Google Scholar 

  11. Möllmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559

    Article  PubMed  Google Scholar 

  12. Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtländer T, Kuck KH, Mehta RH (2016) Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J 37(28). doi:10.1093/eurheartj/ehw190

    Google Scholar 

  13. Figulla HR, Cremer J, Walther T, Gerckens U, Erbel R, Osterspey A, Zahn R (2009) Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 3:199–206

    Article  Google Scholar 

  14. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, de Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012(33):2451–2496

    Google Scholar 

  15. Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrøm T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Søndergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65:2184–2194

    Article  PubMed  Google Scholar 

  16. Søndergaard L, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Ngo AT, Olsen NT, Chang Y, Franzen OW, Engstrøm T, Clemmensen P, Olsen PS, Thyregod HG (2016) Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv 9:e003665

    Article  PubMed  Google Scholar 

  17. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Akin JJ, Davidson MJ, Smith CR, PARTNER trial investigators (2015) 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2485–2491

    Article  PubMed  Google Scholar 

  18. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG, PARTNER 1 trial investigators (2015) 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484

    Article  PubMed  Google Scholar 

  19. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ, CoreValve US Clinical Investigators (2016) 3‑year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67:2565–2574

    Article  PubMed  Google Scholar 

  20. Eggebrecht H, Mehta RH (2016) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033

    Article  PubMed  Google Scholar 

  21. Holmes DR Jr, Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, Peterson ED, Rumsfeld JS, Shahian DM, Thourani VH, Tuzcu EM, Vemulapalli S, Hewitt K, Michaels J, Fitzgerald S, Mack MJ (2015) Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. J Am Coll Cardiol 66:2813–2823

    Article  PubMed  Google Scholar 

  22. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acartürk E, Gohlke-Bärwolf C (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828a, b

    Article  PubMed  Google Scholar 

  23. Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH (2015) Qualitätsreport 2014, S. 10. https://www.sqg.de/sqg/upload/CONTENT/Qualitaetsberichte/2014/AQUA-Qualitaetsreport-2014.pdf. Zugegriffen: 10.08.2016

  24. Schäfer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J, Bijuklic K, Meincke F, Thielsen T, Kreidel F, Kuck KH (2012) Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation. JACC Cardiovasc Interv 5:477–486

    Article  PubMed  Google Scholar 

  25. Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Möllmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103:631–640

    Article  PubMed  Google Scholar 

  26. Sündermann S, Dademasch A, Praetorius J, Kempfert J, Dewey T, Falk V, Mohr FW, Walther T (2011) Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 39:33–37

    Article  PubMed  Google Scholar 

  27. Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M (2011) Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv 4:1218–1227

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K.-H. Kuck.

Ethics declarations

Interessenkonflikt

Die Interessenkonflikte der Autoren finden Sie online auf der DGK-Homepage unter http://leitlinien.dgk.org/ bei der entsprechenden Publikation.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuck, KH., Eggebrecht, H., Elsässer, A. et al. Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI). Kardiologe 10, 282–300 (2016). https://doi.org/10.1007/s12181-016-0082-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-016-0082-4

Schlüsselwörter

Keywords

Navigation